About Kiran Turaga
- Accolades
-
-
Peritoneal Mesothelioma
-
Team Leader
-
Hyperthermic Intraperitoneal Chemotherapy
-
Robotic Surgery
-
Excellence in Research
-
Board Certified in Surgery
-
Get to Know Dr. Kiran K. Turaga
Dr. Kiran Turaga treats a wide range of abdominal and peritoneal diseases at the University of Chicago Comprehensive Cancer Center, where he is director of the Surgical Gastrointestinal Cancer Program.
He joined the mesothelioma program in 2016 after six years at the Medical College of Wisconsin Cancer Center, earning a reputation as a leading specialist in the field of asbestos-related disease.
Turaga has been very successful in treating peritoneal mesothelioma with the combination of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, known as HIPEC.
The heated, high-dose chemotherapy, which is used only in select cancer centers, is administered immediately after surgery and is designed to kill any remaining tumor cells.
Turaga has a special interest in treating advanced malignancies, including cancers that have spread beyond their original sites. He works on colon cancer, appendix cancer and malignant bowel obstructions.
He works closely with oncologist Dr. Hedy Lee Kindler, director of the mesothelioma program at University of Chicago Medicine. They are part of the multidisciplinary tumor board that meets regularly to discuss each patient.
Specialties of Dr. Kiran K. Turaga
-
Gastrointestinal surgery
-
Metastatic cancers
-
Cytoreduction
-
Colon cancer
-
Appendix cancer
-
Melanoma
Dr. Kiran K. Turaga’s Experience and Education
-
University of Chicago Comprehensive Cancer Center
-
Medical College of Wisconsin Cancer Center
-
H. Lee Moffitt Cancer Center; University of Pittsburgh Medical Center (Fellowships)
-
Creighton University Medical Center (Residency)
-
All India Institute of Medical Sciences (M.D.)
Awards and Certifications
-
Sharon Wadina Endowed Professor in Sarcoma Research
-
Lee Biblo Award for Professional Excellence
-
Distinguished Faculty in Program Innovation award
-
Bucksbaum Senior Faculty Scholar for Clinical Excellence
-
General Surgery Board certified
Mesothelioma Clinical Trials Under Kiran Turaga
-
A clinical study to determine if experimental magnetic resonance imaging and ultrasound imaging techniques can improve early detection of peritoneal mesothelioma.
See More Top Mesothelioma Doctors
Publications of Dr. Kiran Turaga
-
Alter, R., Turaga, K. & Lengyel, E. (2020, August 3). Are We Ready for Hyperthermic Intraperitoneal Chemotherapy in the Upfront Treatment of Ovarian Cancer? JAMA Network.
-
Turaga, K. & Girotra, S. (2020, June 2). Are We Harming Cancer Patients by Delaying Cancer Surgery During the COVID-19 Pandemic? Annals of Surgery.
-
Turaga, K. (2019 April 29). Editorial: It Is Time. Annals of Surgical Oncology.
-
Sherman, S. et al. (2018, August 1). Estimating Surgical Risk for Patients With Severe Comorbidities. JAMA Surgery.
Disclaimer: Dr. Kiran Turaga has no professional affiliation with Asbestos.com.

Get a Free Treatment Guide Sent Overnight
Get Yours NowFind Ways to Pay for Treatment Costs
Get StartedFind an Active Mesothelioma Clinical Trial
Find NowGet a Free Treatment Guide Sent Overnight
Find Ways to Pay for Treatment Costs
Find an Active Mesothelioma Clinical Trial
1 Cited Article Sources
The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.
- University of Chicago Medicine. (n.d.). Kiran K. Turaga, MD, MPH. Retrieved from: https://www.uchicagomedicine.org/find-a-physician/physician/kiran-turaga
How did this article help you?
What about this article isn’t helpful for you?
Did this article help you?
Thank you for your feedback. Would you like to speak with a Patient Advocate?
Related Topics
Share this article
Last Modified October 15, 2020